Anika Therapeutics, Inc.: capex
| Value | {"amount": 1326000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-03-31 |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5ed1496b-ea0d-490a-a215-c24fa0375a97
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-22-003350Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/capex/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5ed1496b-ea0d-490a-a215-c24fa0375a97
History
- no predecessors — first report